Jared S Mackenzie (Jared Mackenzie)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Mycobacterium Tuberculosis

Antiretroviral Therapy

Top Venues

Antioxidants (Basel, Switzerland)

EMBO molecular medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Ahmed, Jared S Mackenzie, Liku Tezera, Robert Krause, Barry E Truebody, Diana Garay-Baquero, Sócrates Herrera Valencia, Katya Govender, John Adamson, Hayden Fisher, Jonathan W Essex, Salah Mansour, Paul Elkington, Adrie J C Steyn, Alasdair Leslie
Mycobacterium tuberculosis senses host Interferon-γ via the membrane protein MmpL10. Communications biology 5 (1) (2022)
Yi Cai, Eleni Jaecklein, Jared S Mackenzie, Kadamba G Papavinasasundaram, Andrew J Olive, Xinchun Chen, Adrie J C Steyn, Christopher M Sassetti
Host immunity increases Mycobacterium tuberculosis reliance on cytochrome bd oxidase. PLoS pathogens 17 (7) (2021)
Tafara T R Kunota, Md Aejazur Rahman, Barry E Truebody, Jared S Mackenzie, Vikram Saini, Dirk A Lamprecht, John H Adamson, Ritesh R Sevalkar, Jack R Lancaster, Michael Berney, Joel N Glasgow, Adrie J C Steyn
Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility. Antioxidants (Basel, Switzerland) 10 (8) (2021)
Bei Shi Lee, Kiel Hards, Curtis A Engelhart, Erik J Hasenoehrl, Nitin P Kalia, Jared S Mackenzie, Ekaterina Sviriaeva, Shi Min Sherilyn Chong, Malathy Sony S Manimekalai, Vanessa H Koh, John Chan, Jiayong Xu, Sylvie Alonso, Marvin J Miller, Adrie J C Steyn, Gerhard Grüber, Dirk Schnappinger, Michael Berney, Gregory M Cook, Garrett C Moraski, Kevin Pethe
Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis. EMBO molecular medicine 13 (1) (2020)
Jared S Mackenzie, Dirk A Lamprecht, Rukaya Asmal, John H Adamson, Khushboo Borah, Dany J V Beste, Bei Shi Lee, Kevin Pethe, Simon Rousseau, Inna V Krieger, James C Sacchettini, Joel N Glasgow, Adrie J C Steyn
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. Nature communications 11 (1) (2020)